Professor Ian O. Ellis Professor of Cancer Pathology Nottingham ...

6 downloads 1184 Views 73KB Size Report
Honorary Consultant Pathologist Nottingham City Hospital ... Editorial Management Board & Pathology Sub Editor of “The Breast” (1991-2011). Editorial Board ...
1

Professor Ian O. Ellis Professor of Cancer Pathology Nottingham University, Honorary Consultant Pathologist Nottingham City Hospital Dept Histopathology, City Hospital Campus, Nottingham University Hospitals, Hucknall Rd, Nottingham, NG7 1DD, UK Tel.: +44 115 969 1169 Fax.: +44 115 962 7768 E-mail: [email protected]

Academic degrees BMedSci, University of Nottingham (1976) BM BS, University of Nottingham (1978) FRCPath, Royal College of Pathologists (1985) Prizes and honors North Nottingham Consultants Prize (1978) Macallam prize (1984) Becton Dickinson Travelling Fellowship (1990) Runner up, UK Wine Taster of the Year (1991) Pathological Society Slide Seminar Winner (1996) Editorial board Editorial Management Board & Pathology Sub Editor of “The Breast” (1991-2011) Editorial Board of “Analytic Cellular Pathology” (1992-1999) Editorial Board of “Cytopathology” (1994-2005) Editorial Advisory Board of “Current Diagnostic Pathology”(1994-present) Editorial Board of “Advances in Anatomic Pathology” (2000-present) Editorial Board of Endocrine related cancer (2001-present) Editorial Board of “Histopathology” (2002-present) Editorial Advisory Panel of Future Oncology (2004-present) Editorial Board of “Journal of Pathology” (2007-present)

Selected publications Curtis C et al The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012 Apr 18. [Epub ahead of print] Ross-Innes CS et al, Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 481(7381):389-93 (2012)



Biosketch_Ellis I.O.

2

Rakha EA, Martin S, Lee AH, Morgan D, Pharoah PD, Hodi Z, Macmillan D, Ellis IO. The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer. 2011 Dec 16. [Epub ahead of print] Cuzick J, Sestak I, Pinder SE, Ellis IO, Forsyth S, Bundred NJ, Forbes JF, Bishop H, Fentiman IS, George WD. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol. 12(1):21-9 (2011) Mohammed RA, Martin SG, Mahmmod AM, Macmillan RD, Green AR, Paish EC, Ellis IO.Objective assessment of lymphatic and blood vascular invasion in lymph nodenegative breast carcinoma: findings from a large case series with long-term followup. J Pathol. 223(3):358-65 (2011) Abdel-Fatah TM, Powe DG, Agboola J, Adamowicz-Brice M, Blamey RW, Lopez-Garcia MA, Green AR, Reis-Filho JS, Ellis IO. The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers. J Pathol.220(4):41934 (2010) Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, ElSayed ME, Benhasouna A, Brunet JS, Akslen LA, Evans AJ, Blamey R, Reis-Filho JS, Foulkes WD, Ellis IO. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res. 15(7):2302-10 (2009) Elsheikh SE, Green AR, Rakha EA, Powe DG, Ahmed RA, Collins HM, Soria D, Garibaldi JM, Paish CE, Ammar AA, Grainge MJ, Ball GR, Abdelghany MK, Martinez-Pomares L, Heery DM, Ellis IO. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 69(9):3802-9 (2009) Rakha EA, El-Sayed ME, Lee AH, Elston CW, Grainge MJ, Hodi Z, Blamey RW, Ellis IO. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol. 26(19):3153-8 (2008) Blamey RW, Ellis IO, Pinder SE, Lee AH, Macmillan RD, Morgan DA, Robertson JF, Mitchell MJ, Ball GR, Haybittle JL, Elston CW. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer. 43(10):1548-55. (2007) Selected text books Ellis IO Pinder SE and Lee AHS. Breast Pathology. In Diagnostic Histopathology of Tumours Third Edition. Ed. Fletcher CDM. Churchill Livingstone Elsevier, 2007. WHO Classification of Gynaecological Tumours (including breast): Pathology and Genetics (Blue Books). IARC Publications, Lyon 2003 International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Volume 7. Breast Cancer Screening.IARC Press Lyon 2002 

Biosketch_Ellis I.O.

3

Ellis IO and Elston CW, Histologic Grade. In Breast Pathology.2nd ed. Eds O’Malley FP and Pinder SE. Churchill Livingstone Elsevier 2011 Ellis IO and Elston CW. Breast Tumours. In Diagnostic Histopathology of Tumours Second Edition. Ed. Fletcher CDM. Churchill Livingstone London 2000



Biosketch_Ellis I.O.